Publications

Beena Negi, Aarshiya Kwatra. A Review of Recent Progress on the Anticancer Activity of Hetero-cyclic Compounds. SynOpen 2024, 8, 185–210

Ramya Vishwanath, Beena Negi. Conventional and green methods of synthesis of silver nanoparticles and their antimicrobial properties. Curr. Res. Green Sust. Chem. 2021, 4, 100205.

Shristi Rawat, Diwan S Rawat, Beena Negi. Synthesis, in silico pharmacokinetic analysis and anticancer activity evaluation of benzothiazole-triazole hybrids. Indian J. Chem.-Sec B (IJC-B) 2021, 60 (3), 409-417

Beena Negi, Diwan S Rawat. Antituberculosis activity evaluation of thymol Schiff bases. Chemistry & Biology Interface 2018, 8, 4, 244-254. 

Beena Negi, Diwan S Rawat, Synthesis, Characterization and Antituberculosis Activity of Novel Thymol Triazole Hybrids, Indian J. Hetro. Chem. 2018, 28, 113-124. (Impact factor: 0.16)

Beena Negi, Prija Poonan, Mohammad Fawad Ansari, Deepak Kumar, Sakshi Aggarwal, Ramandeep Singh, Amir Azam, Diwan S. Rawat. Synthesis, antiamoebic activity and docking studies of metronidazole triazole-styryl hybrids. Eur. J. Med. Chem. 2018, 150, 633-641. (Impact factor: 4.519)

Beena Negi, Deepak Kumar and Diwan S. Rawat. Marine peptides as anticancer agents: A remedy to mankind by nature. Current Protein & Peptide Science 2017, 18, 1-20. (Impact factor: 2.576)

Beena Negi, Deepak Kumar, Widuranga Kumbukgolla, Sampath Jayaweera, Prija Ponnan, Ramandeep Singh, Sakshi Agarwal, Diwan S. Rawat, Anti-methicillin resistant Staphylococcus aureus activity, synergism with oxacillin and molecular docking studies of metronidazole triazole Hybrids. Eur. J. Med. Chem. 2016, 115, 426-437. (Impact factor: 4.519)

Deepak Kumar, Beena Negi, Diwan S. Rawat. The anti-tuberculosis agents under development and the challenges ahead. Fut. Med. Chem. 2015, 7, 1981-2003. (Impact factor: 3.556)

Deepak Kumar, Garima Khare, Beena Negi, Saqib Kidwai, Anil K. Tyagi, Ramandeep Singh, DS Rawat. Novel isoniazid-amidoether derivatives: Synthesis, characterization and antimycobacterial activity evaluation. Med. Chem. Commun. 2015, 6, 131-137. (Impact factor: 2.608)

Deepak Kumar, Beena Negi, Garima Khare, Anil K. Tyagi, Ramandeep Singh, Diwan S Rawat. Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro antimycobacterial activity evaluation. Eur. J. Med. Chem. 2014, 81, 301-313. (Impact factor: 4.519).

Beena Negi, K. Kranthi Raj, Shadab Miyan Siddiqui, Dittakavi Ramachandran, Amir Azam, and Diwan S. Rawat. In vitro antiamoebic activity evaluation and docking studies of metronidazole–triazole hybrids. Chem. Med. Chem. Commun. 2014, 9, 2439–2444. (Impact factor: 3.225)

Beena, Deepak Kumar, Widuranga Kumbukgolla, Sampath Jayaweera,MaiAnn Bailey, Torey Alling, Juliane Ollinger, Tanya Parish, Diwan S Rawat. Antibacterial activity of adamantyl substituted cyclohexane diamine derivatives against methicillin resistant Staphylococcus aureus and Mycobacterium tuberculosis. RSC Adv. 2014, 4, 11962–11966. (Impact factor: 3.108)

Beena, Deepak Kumar, Mai Ann Bailey, Tanya Parish, Diwan S Rawat. Synthesis and antituberculosis activity evaluation of cyclohexane-1,2-diamine derivatives. Chem. Biol. Interface 2014, 4, 1-14.

Beena; Rawat, D. S. Antituberculosis drug research: A critical overview. Med. Res. Rev. 2013, 33, 693–764. (Impact factor: 8.431).

Beena; Kumar, D.; Rawat, D. S. Synthesis and antioxidant activity of thymol and carvacrol based Schiff bases. Bioorg. Med. Chem. Lett. 2013, 23, 641–645. (Impact factor: 2.486).

Beena; Joshi, S.; Kumar, N.; Kidwai, S.; Singh, R.; Rawat, D. S. Synthesis and antitubercular activity evaluation of novel unsymmetrical cyclohexane-1,2-diamine derivatives. Arch. Pharm. Chem. Life Sci. 2012, 345, 896–901. (Impact factor: 1.53).

Beena; Kumar, N.; Rohilla, R. K.; Roy, N.; Rawat, D. S. Synthesis and antibacterial activity evaluation of metronidazole-triazole conjugates. Bioorg. Med. Chem. Lett. 2009, 19, 1396–1398. (Impact factor: 2.454).

Kumar, N.; Khan, S. I.; Beena; Rajalakshmi, G.; Kumaradhas, P.; Rawat, D. S.Synthesis, antimalarial activity and cytotoxicity of substituted 3,6-diphenyl-[1,2,4,5]tetraoxanes. Bioorg. Med. Chem. 2009, 17, 5632–5638. (Impact factor: 2.92).